MENU
+Compare
INDP
Stock ticker: NASDAQ
AS OF
Aug 4, 04:59 PM (EDT)
Price
$7.30
Change
-$0.00 (-0.00%)
Capitalization
4.18M

INDP Indaptus Therapeutics Inc Forecast, Technical & Fundamental Analysis

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INDP with price predictions
Aug 01, 2025

INDP's RSI Indicator stoops into oversold zone

The RSI Oscillator for INDP moved into overbought territory on August 01, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INDP advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

INDP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on INDP as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for INDP turned negative on July 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

INDP moved below its 50-day moving average on July 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for INDP crossed bearishly below the 50-day moving average on July 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.493) is normal, around the industry mean (17.575). P/E Ratio (0.000) is within average values for comparable stocks, (58.514). INDP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.535). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (277.625).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INDP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INDP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INDP is expected to report earnings to fall 40.62% to -18 cents per share on August 18

Indaptus Therapeutics Inc INDP Stock Earnings Reports
Q2'25
Est.
$-0.19
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.11
The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -18 cents. With 9.61K shares outstanding, the current market capitalization sits at 4.18M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGEN1.760.09
+5.39%
Precigen
SRBK14.030.07
+0.50%
SR Bancorp
RRX147.51-1.68
-1.13%
Regal Rexnord Corp
APGE37.24-0.51
-1.35%
Apogee Therapeutics
TOVX0.42-0.01
-2.12%
Theriva Biologics Inc

INDP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-10.54%
UNCY - INDP
53%
Loosely correlated
-3.23%
ALT - INDP
45%
Loosely correlated
-2.17%
CDTX - INDP
41%
Loosely correlated
-0.65%
IMAB - INDP
38%
Loosely correlated
+30.35%
RVPH - INDP
30%
Poorly correlated
-6.90%
More